Lv611
3150 积分 2024-03-29 加入
PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
2小时前
已完结
OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
8天前
已完结
Fibroblast Activation Protein-Targeted Theranostics: Current Status in Clinical Development
12天前
已完结
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment
12天前
已完结
Fibroblast activation protein (FAP) as a possible target of an antitumor strategy
12天前
已完结
Regulation of Fibroblast Activation Protein-α Expression: Focus on Intracellular Protein Interactions
12天前
已完结
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
12天前
已完结
A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule–Drug, Antibody–Drug, and Peptide–Drug Conjugates
12天前
已完结
In vivo activation of FAP-cleavable small molecule-drug conjugates for the targeted delivery of camptothecins and tubulin poisons to the tumor microenvironment
12天前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
12天前
已完结
皖公网安备34019202002308
